Antibodies are blood proteins produced in response to and counteracting a specific antigen. Antibodies combine chemically with substances that the body recognizes as alien, such as bacteria, viruses, and foreign substances in the blood.
Monitoring with Flow Cytometry provides a range of diverse information about immune and non-immune cellular (sub)populations and their activation status. This is achieved by exploiting a pan...
Antibody-drug conjugates (ADCs) are transforming oncology with their ability to deliver potent cytotoxic agents directly to tumor cells, combining the targeting precision of monoclonal antib...
The global spread of Highly Pathogenic Avian Influenza (HPAI), particularly the H5N1 2.3.4.4b clade, underscores the urgent need for rapid antibody development and characterization. Because...
Multiplexed immunofluorescence (mIF) imaging has emerged as a powerful approach for spatially resolved, single-cell–level characterization of complex tissues, enabling simultaneous vis...
Recombinant antibodies offer clear advantages over conventional polyclonal and hybridoma-derived antibodies by providing sequence-defined, renewable, and highly reproducible reagents. Their...
Monitoring with Flow Cytometry provides a range of diverse information about immune and non-immune cellular (sub)populations and their activation status. This is achieved by exploiting a pan...
Antibody-drug conjugates (ADCs) are transforming oncology with their ability to deliver potent cytotoxic agents directly to tumor cells, combining the targeting precision of monoclonal antib...
The global spread of Highly Pathogenic Avian Influenza (HPAI), particularly the H5N1 2.3.4.4b clade, underscores the urgent need for rapid antibody development and characterization. Because...
Multiplexed immunofluorescence (mIF) imaging has emerged as a powerful approach for spatially resolved, single-cell–level characterization of complex tissues, enabling simultaneous vis...
Recombinant antibodies offer clear advantages over conventional polyclonal and hybridoma-derived antibodies by providing sequence-defined, renewable, and highly reproducible reagents. Their...
Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The...
Antibody-drug conjugates (ADCs) are transforming oncology by combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. Yet, developing effective ADCs requires ove...
Fluid biomarkers for Alzheimer’s disease (AD) have advanced rapidly during the past several years driven by breakthroughs including development of ultrasensitive and multiplexing techn...
Efficient purification of plasmids, proteins, and antibodies is critical for drug target identification, drug candidate development, and fundamental research. However, traditional column-bas...
Be Part of the Global Proteomics Movement – Join Olink Proteomics World After the incredible success of Olink Proteomics World 2024 —which brought together over 20 global speaker...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10 th Annual Drug Discovery & Development Virtual Eve...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development...
Announcing xMAP® Connect 2025 Virtual Webinar Series Join us for an immersive virtual experience about Multiplexing - From Data to Discovery - starting Wednesday, October 1st, with webin...
Be Part of the Global Proteomics Movement – Join Olink Proteomics World After the incredible success of Olink Proteomics World 2024 —which brought together over 20 global speaker...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10 th Annual Drug Discovery & Development Virtual Eve...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development...
Announcing xMAP® Connect 2025 Virtual Webinar Series Join us for an immersive virtual experience about Multiplexing - From Data to Discovery - starting Wednesday, October 1st, with webin...
Discover a new and simple way to advance your protein research with automated solutions from Bio-Techne! Our virtual event series will showcase how you can leverage these revolutionary techn...
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomics on immunology, oncology, neuroscience, ageing,...
The 2025 “Scripting the Future Summit,” hosted by GenScript, is the premier virtual gathering for scientists, biotech innovators, and pharmaceutical leaders exploring the next wa...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 8 th Annual Event in the Drug Discovery & Development...